Education and Training
Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma
To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- procedure: high dose chemo then auto hematopoietic cell transplant
Eligibility
Inclusion Criteria:- relapsed NHL Exclusion Criteria:- liver dysfunction
Ages Eligible for Study
4 Weeks - 75 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
BMT Refferals
6507230822
Not Recruiting